Avoid the Inappropriate Use of Antipsychotic Medication in Anxiety Disorders
AI Summary
Blue Cross Blue Shield Texas issued new guidance discouraging inappropriate use of antipsychotic medications for anxiety disorders, as most are not FDA-approved for these conditions. The policy emphasizes careful risk-benefit assessment and provides clinical practice guidelines for anxiety disorder treatment.
Action Required
Immediately: Providers prescribing antipsychotic medications for anxiety disorders must document thorough symptom assessment and risk-benefit analysis in patient records. Review current anxiety disorder patients on antipsychotics to ensure appropriate clinical justification. Access provided clinical practice guidelines through Availity Essentials for evidence-based treatment protocols.
Plan Types
All Plans
States
TX
Specialties
psychiatry, family-medicine, internal-medicine, pediatrics